chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tired; Weak; vaccine reaction; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired), ASTHENIA (Weak) and VACCINATION COMPLICATION (vaccine reaction) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired) (seriousness criterion hospitalization), ASTHENIA (Weak) (seriousness criterion hospitalization) and VACCINATION COMPLICATION (vaccine reaction) (seriousness criterion hospitalization). At the time of the report, FATIGUE (Tired), ASTHENIA (Weak) and VACCINATION COMPLICATION (vaccine reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: low (Low) Dropped. On an unknown date, Ejection fraction: increased 10 points Increased 10 points. On an unknown date, Heart rate: 125-135 (abnormal) High heart rate 125-135..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was hospitalized for vaccine reaction to Moderna vaccine within 24 hours, with high heart rate 125-135 and dropped BP and tired and weak with 24 hours of the vaccine. Patient had another echo on 18 Nov 2021 and there was no change since the last one (Results not provided).  Company comment: This case concerns a 57-year-old female patient, with no reported medical history, who experienced the serious, unexpected events of vaccine complication, fatigue and asthenia. The events occurred within 24 hrs after unspecified dose of mRNA 1273 vaccine. The patient was hospitalized for vaccine reaction, fatigue and weakness, her BP dropped and heart rate increased. The rechallenge is not applicable as there is no information regarding dose number. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a 57-year-old female patient, with no reported medical history, who experienced the serious, unexpected events of vaccine complication, fatigue and asthenia. The events occurred within 24 hrs after unspecified dose of mRNA 1273 vaccine. The patient was hospitalized for vaccine reaction, fatigue and weakness, her BP dropped and heart rate increased. The rechallenge is not applicable as there is no information regarding dose number. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.
Sickness; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had very mild case of shingles ten years ago ). Previously administered products included Shingles shot (received Shingles shot after having shingles ten years ago) and Shingles shot (received 1st Shingles shot an an unknown day).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingles shot which made him/her sick.
Sexually on fire; This spontaneous case was reported by a consumer and describes the occurrence of LIBIDO INCREASED (Sexually on fire) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced LIBIDO INCREASED (Sexually on fire). At the time of the report, LIBIDO INCREASED (Sexually on fire) outcome was unknown.            The concomitant medications were not reported. The treatment information was not provided.   The action taken with mRNA 1273 with the events was considered as not applicable.
At around 4pm I started to feel cold. 30 mins later I started shivering and feeling cold and very sick with muscle aches all over the body with puncture maximum in left flank on a scale from 1-10 probably 9!I wasn't able to get up from the couch and had shivering until 2-3 hours later. I delayed taking Ibuprofen to not reduce the efficiency of the vaccine but couldn't endure the chills and shivering as well as the massive pain all over my body. I started with 200 mg Ibuprofen, which helped with all 3 symptoms at least as far as I was able to sit instead of lie all the time.
PREVNAR 13, Hepatitis A, PROQUAD and ActHib ordered. PROQUAD was not given, and ACTHib was given twice.
The patient received a third dose in error.  The patient has not reported any adverse effects from the third dose.
Pt recv vax on 1/14/99; on same day pt exp hypoglycemia x 12 hr; tx=glucose
Patient was given an extra dose of Flu vaccine .5cc in right arm. Nurse giving injection thought it was Pneumonia.
Mild arm soreness followed by generalized aching, unable to catch full breath, fever.  Had mild achiness day following vaccine.
Feeling very sick; Sweating; Couldn't get out of the bed for 4 days; Very bad joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Feeling very sick), HYPERHIDROSIS (Sweating), SOMNOLENCE (Couldn't get out of the bed for 4 days) and ARTHRALGIA (Very bad joint pain) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ILLNESS (Feeling very sick), HYPERHIDROSIS (Sweating), SOMNOLENCE (Couldn't get out of the bed for 4 days) and ARTHRALGIA (Very bad joint pain). At the time of the report, ILLNESS (Feeling very sick) and HYPERHIDROSIS (Sweating) outcome was unknown, SOMNOLENCE (Couldn't get out of the bed for 4 days) had resolved and ARTHRALGIA (Very bad joint pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
No additional AE reported.; Nurse calling in TE case 02215786 reports 1 dose of VARIVAX stored outside of recommended range administered to 1 patient.; This spontaneous report was received from a nurse and refers to an 1-year-old female patient. The patient's medical history, current conditions and concomitant medications were not reported.  On 30-JUL-2022, the patient was vaccinated with 1 dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot #U030162, expiration date: 28-SEP-2023 (anatomical location and route of administration were not provided) for prophylaxis, after the temperature excursion happened (Improper storage of product in use). Administrated vaccine varicella virus vaccine live (oka/merck) (VARIVAX) was stored at 35 Fahrenheit (F) for 1 hour and 59 minutes. There was no previous temperature excursion.  There were no adverse events reported.
5 days after receiving Moderna vaccination suffer acute myocardial infraction. Requiring stent placement of the right coronary artery. Recovering from MI.
INTENSE CHILLS, BODY ACHES, NAUSE, FATIGUE, SLEEPINESS,LOSS OF APPETITE. FAINTED-YES FAINTED FALLING BACK AND HITTING MY HEAD ABOUT 3 AM IN MORNING.  I AM ON WARFARIN FOR BLOOD CLOTS
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date, the unspecified number of patients were vaccinated with unspecified doses of RECOMBIVAX HB (Lot number, expiry date, route and dose were not reported) that were left sitting out at unspecified temperature for an unspecified time frame. This had occurred at an unspecified location in the district where the reporter works. No adverse effects reported. Additional information has been requested.
pt recvd vax & was fussy all wk; on weekend began to run fever 102-103 R & had high pitch cry; MD was notified; pt stated on Ampicillin p/temp rised 104 R; broke out in rash on Monday;
Worst migraine I have ever experienced for almost 10 hours. could not stomach anything.  period was late every month by 4-5 days for 4+ months following 2nd dose. my period hsa never been late since I started menstruating at 12 years old.  I also became pregnant in Dec 2020 and miscarried at 6 weeks pregnant. I was seen at the ER For this miscarriage
14 days post vaccination developed: chest pain, back pain,  paresthesia of bilateral upper extremities. CXR, EKG and Lab work done. Symptoms not disabling yet present; musculoskeletal pain in upper extremities with paresthesia
Breakthrough case admission after 2 vaccines Moderna 2/21/21 Lot# 005M20A;  Moderna 3/12/21 Lot# 002B21A
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Pharmacist). The reporter is the patient. A 32-year-old male patient received BNT162b2 (BNT162B2), on 17Mar2021 as dose 1, single (Lot number: EN6204), on 08Apr2021 as dose 2, single (Lot number: ER8733) and on 15Oct2021 as dose 3 (booster), single (Lot number: 30125BA) at the age of 31 years for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. No known allergies. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.; Sender's Comments: Based on the information currently available, a causal association between the reported event and BNT162b2 cannot be excluded.
This spontaneous report was received from a physician via a company representative, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 18-OCT-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 "23-10pk-0.5ml-SD PFS LLok wTip, which had a lot number of  M005287 and expiration date on 08-OCT-2017 (route of administration and anatomical location were not reported). There were no concomitant medications provided. No adverse effects reported. No product quality complaint was involved. On an unspecified date, the PNEUMOVAX 23 had two temperature excursions; one for 32 hours with lowest recorded temperature of 34 F (1.1 Celsius) and other one for 24 hours with lowest recorded temperature of 32 F (0 Celsius). The lowest recorded temperature was 32 F (0 Celsius) and the highest recorded temperature was not mentioned. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". This is one of several cases from the same reporter. Additional information has been requested.
he couldn't walk for several days.; It took 20 minutes to  get to his shower which is 15 feet away, Difficulty walking and standing for prolonged periods; feet (bilateral), hands (lateral) pain; Swelling in joints; Had to shuffle to get to the shower; pain in joints(knees (bilateral), ankles (bilateral), hips (bilateral)); This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (he couldn't walk for several days.), GAIT DISTURBANCE (It took 20 minutes to  get to his shower which is 15 feet away, Difficulty walking and standing for prolonged periods), PAIN IN EXTREMITY (feet (bilateral), hands (lateral) pain), JOINT SWELLING (Swelling in joints) and LIMB DISCOMFORT (Had to shuffle to get to the shower) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included MS, Sulfonamide allergy and Drug allergy (Allergy to Clindamycin.). Concomitant products included METOPROLOL for Atrial fibrillation, EZETIMIBE (ZETIA) and SIMVASTATIN for Cholesterol, LISINOPRIL for Hypertension, OCRELIZUMAB from 15-Aug-2021 to an unknown date for Multiple sclerosis.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GAIT INABILITY (he couldn't walk for several days.), GAIT DISTURBANCE (It took 20 minutes to  get to his shower which is 15 feet away, Difficulty walking and standing for prolonged periods), PAIN IN EXTREMITY (feet (bilateral), hands (lateral) pain), JOINT SWELLING (Swelling in joints), LIMB DISCOMFORT (Had to shuffle to get to the shower) and ARTHRALGIA (pain in joints(knees (bilateral), ankles (bilateral), hips (bilateral))). The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 dosage form. At the time of the report, GAIT INABILITY (he couldn't walk for several days.), GAIT DISTURBANCE (It took 20 minutes to  get to his shower which is 15 feet away, Difficulty walking and standing for prolonged periods), PAIN IN EXTREMITY (feet (bilateral), hands (lateral) pain), JOINT SWELLING (Swelling in joints), LIMB DISCOMFORT (Had to shuffle to get to the shower) and ARTHRALGIA (pain in joints(knees (bilateral), ankles (bilateral), hips (bilateral))) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was prescribed with steroids.   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Significant follow-up received on 13-Aug-2021 included historical condition, concomitant drugs and  events added. On 01-Sep-2021: Follow-up contains new event limb discomfort
Started as numbness in inside right thigh muscle in an area the size of a baseball. Over the following week the area extended to my right groin area and then to my right hip bone. For two weeks level  8-10 pain accompanied the numb and itchy symptoms. The pain gradually subsided and the numbness remains today. The area affected is from my right inner thigh muscle to my groin area, no longer extending to my hip. I have been seen by 2 doctors and had physical therapy including dry needling. My doctor plans to send me to a neurologist next
Severe diarrhea by 11:00 pm the night of the vaccine. Time course: 26 days straight and going strong.
Patient is 64 years old and received Fluzone HD in error (formula recommended for age 65 and over)
Pfizer-BioNTech COVID-19 Vaccine EUA  Injection site pain began around 12:30 PM Pacific Time, approximately 3 hours after vaccination. Mild headache began around 4:00 PM Pacific Time.
tongue slightly swollenand tingly; tongue slightly swollenand tingly; sweating; chills; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown), via an unspecified route of administration in the left arm on 22Mar2021 at 14:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EJ1685), via an unspecified route of administration in the left arm on 01Mar2021 at 14:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 12:00, the patient experienced muscle aches, tongue slightly swollen and tingly, chills, and sweating. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had not received any treatment for the events muscle aches, tongue slightly swollen and tingly, chills, and sweating. The clinical outcomes of muscle aches, tongue slightly swollen and tingly, chills, and sweating was resolved on an unknown date in Mar2021 at the time of this report.   No follow-up attempts are possible. No further information is expected.
I have been having some issues since you gave me my HEP B vaccine. It started Friday morning and has been getting worse ever since. Started with the tips of my fingers and toes on my right side going numb. As they day went on the numbness spread. As the weekend progress that spread to both hands and feet and up to my knees and elbows and had that itchy numbness in my feet. After that, my right arm and shoulder have been in extreme pain. I have pins and needles in both feet and hands 24/7. Have you ever had anyone experience this? And if so, how did they make it stop? I am at the point where I just want to cut my arm off to make the pain stop.
Red bump that is warm to the touch and itchy at injection site. Showed up 7 days after first injection.
w/in 5min, pt started itching & devel hives;also vomited;given epi, vomited again;given epi 20min later, pt improved-hives subsided;itching dec, no vomiting;
Physician reports improperly stored MMR was administered on an unspecified date to an unspecified patient; No additional adverse effects reported; This spontaneous report was received from a physician referring to an unspecified patient of unknown age and gender. There was no information regarding his/her pertinent medical history, past medication, current conditions, drug reactions or allergies provided.     On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, vaccination scheme and route of administration were not provided) ; lot number 1660945 was determined as not valid for measleas, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R-II), expiration date was reported as 13-FEB-2021) as prophylaxis (product storage error). Concomitant therapies included sterile diluent.   It was reported that the vaccine was stored in a temperature of 9 degrees Celcius (°C) in a timeframe of 48 hours. There was no previous temperature excursion reported, and it was reported that a digital data logger was involved.  This case was considered as non-valid due to the lack of patient's identifiers.
his arm was mildly sore for a few hours after first dose; contents of the vaccine leaked out during administration, drops on the chair and arm was wet; contents of the vaccine leaked out during administration, drops on the chair and arm was wet; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (contents of the vaccine leaked out during administration, drops on the chair and arm was wet), DEVICE CONNECTION ISSUE (contents of the vaccine leaked out during administration, drops on the chair and arm was wet) and MYALGIA (his arm was mildly sore for a few hours after first dose) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jun-2021, the patient experienced UNDERDOSE (contents of the vaccine leaked out during administration, drops on the chair and arm was wet) and DEVICE CONNECTION ISSUE (contents of the vaccine leaked out during administration, drops on the chair and arm was wet). On an unknown date, the patient experienced MYALGIA (his arm was mildly sore for a few hours after first dose). At the time of the report, UNDERDOSE (contents of the vaccine leaked out during administration, drops on the chair and arm was wet), DEVICE CONNECTION ISSUE (contents of the vaccine leaked out during administration, drops on the chair and arm was wet) and MYALGIA (his arm was mildly sore for a few hours after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included Cholesterol medication. Treatment information was not provided.   This case was linked to MOD-2021-265307 (Patient Link).
Hot flash then developed rash to face, below chin, upper chest. Did not check anywhere else.
Migraine and extreme fatigue started 14 hours later, then developed a huge lump in left armpit the size of a tennis ball.
Hours after receiving a shot decedent felt numbness in arms and legs, weakness, dry mouth that lasted until he passed away on 2/2/2022. He was progressively feeling worst and had breating problems.
fully vacillating since February. I got Covid.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (fully vacillating since February. I got Covid.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (fully vacillating since February. I got Covid.). At the time of the report, COVID-19 (fully vacillating since February. I got Covid.) outcome was unknown.            Concomitant product was not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to events was not applicable.
Local pain, temperature 100.2, child, nausea, headache, body aches, lightheaded for about 24 hours
NEUROPATHY 5/19/2021 UNSPECIFIED ANXIETY DISORDER  RESPIRATORY FAILURE, UNSPECIFIED ACUITY 10/5/2021 UNSPECIFIED ANXIETY DISORDER
Headache Throat horse, difficult to move, migraine headache. SOB, lethargic Narrative:  Took Benadryl at home
Patient became very ill (body ache/stiffness). Patient recovered after his doctor administered prednisone.
Patient states she received J&J COVID19 vaccine today at clinic site at 10:30am. States she noticed facial swelling starting at 11:30am. Patient went out to lunch and returned home and called COVID19 hotline to report symptoms. States when the swelling was at it's worst, it was difficult to see facial structure of cheek bones which she can usually see. States symptoms are improving facial swelling has 'mostly resolved' with mild swelling around eyes persisting. No OTC medications taken. Denies vomiting/itching/nausea/rash/SOB. Talking comfortably on the phone. Denies need to clear throat.
Patient states her left arm was swollen, red, warm to the touch, and itchy below shoulder and above elbow.  Patient also states she felt sick that evening and had a couple episodes of vomiting.
Tested NAAT positive for COVID 11/22/21 after being fully vaccinated.
Employee reports rapid heart rate, feeling like she was going to pass out, vomiting.  She also has redness at the injection site with swelling